Low stroke rate and few thrombo-embolic events after HeartMate II implantation under mild anticoagulation

Abstract

Compared with the literature, even a mild anticoagulation protocol does not increase the risk of thrombotic events, but reduces bleeding events in the use of an HM II LVAD.